Newcells Biotech

Newcells Biotech.

Sector

Healthcare

Nature of business

The development of an iPS cell platform, iPc assays for diagnostics, and using iPSC cells for cell technology based for drug discovery.

Description of deal

NVM invested £1.5m development capital.

Contact Tim Levett